N6-methyladenosine promotes temozolomide resistance through non-canonical regulation of mRNA stability in glioblastoma cells
Dangelmaier, E. A.; Fang, D.; Htet, K. S.; Harry, N. S.; Pascoe, R.; Yang, J. W.; Wang, C. D.; Nachtergaele, S.
Show abstract
N6-methyladenosine (m6A) is a critical regulator of mRNA processing and function, impacting nearly every step of the mRNA lifecycle. Changes in m6A status have been implicated in many different types of cancer, including glioblastoma where acquired resistance to temozolomide remains a major clinical challenge. We established glioblastoma cell culture models of acquired temozolomide resistance and analyzed the role of m6A in controlling resistance-associated pathways. We show that m6A stabilizes key genes and pathways promoting temozolomide resistance in glioblastoma, including MGMT, the enzyme that repairs primary temzolomide-induced DNA damage, and PI3K/Akt signaling, a major driver of chemoresistance. Pharmacological inhibition of the m6A methyltransferase METTL3 destabilizes MGMT and other critical mRNAs, restoring temozolomide sensitivity. Collectively, our results suggest that genes associated with temozolomide resistance are stabilized by m6A methylation, even as the majority of the transcriptome remains subject to m6A-mediated mRNA decay. Moreover, these data highlight METTL3 inhibition as a promising therapeutic approach to overcoming temozolomide resistance in glioblastoma.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor 94%
- GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasis 94%
- NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors 94%
Similar papers in this journal
- RNA methylation influences TDP43 binding and disease pathogenesis in models of amyotrophic lateral sclerosis and frontotemporal dementia 93%
- Transcription elongation factor ELOF1 is required for efficient somatic hypermutation and class switch recombination 92%
- Productive mRNA Chromatin Escape is Promoted by PRMT5 Methylation of SNRPB 92%
Similar papers in this journal
- IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy 95%
- Recruitment of the m6A/Am demethylase FTO to target RNAs by the telomeric zinc finger protein ZBTB48 95%
- Single cell decoding of drug induced transcriptomic reprogramming in triple negative breast cancers 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.